Venlafaxine Hydrochloride Extended-Release Capsules, USP 37.5mg, packaged in a) 90-count bottles (NDC 68382-034-16) and b)1000-count bottles (NDC 68382-034-10), Rx only, Mfg. by: Zydus Lifesciences Ltd. Ahmedabad, India; Dist. by: Zydus Pharmaceuticals (USA) Inc. Pennington, NJ 08534
Published July 31, 2024 · Recall initiated: June 21, 2024
Summary
FDA records drug Class II recall D-0617-2024, published July 31, 2024 and initiated June 21, 2024. Recalling firm: Zydus Pharmaceuticals (USA) Inc; Status: Terminated; Reported quantity: a) 13,128 bottles; b) 252 bottles; Lot: Lot #: a) M213175, Exp. Date 09/2024; b) M213176, Exp. Date 09/2024. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Failed Dissolution Specifications: Out-of-specification results observed for dissolution testing at the 8-hour and 12-hour pull intervals.
What to do
Voluntary: Firm initiated · Letter
Get an email if VENLAFAXINE HYDROCHLORIDE has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- VENLAFAXINE HYDROCHLORIDE
- Manufacturer
- Zydus Pharmaceuticals (USA) Inc
- Distributor
- Nationwide within the United States
- UPC
- 0368382034106
- Lot
- Lot #: a) M213175, Exp. Date 09/2024; b) M213176, Exp. Date 09/2024
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAHemp Bombs CBD Pain Freeze (menthol 4%), 1000mg, 4 oz bottles, Distributed by: Global Widget 8419 Sunstate St,July 31, 2024
- FDAComplete 30C/200C Homeopathic Kit, Contains: One hundred 1/2 dram vials of homeopathic medicines, WashingtonJuly 31, 2024
- FDAHemp Bombs CBD Pain Freeze (menthol 4%), 400mg, 4 oz bottles, Distributed by: Global Widget 8419 Sunstate St,July 31, 2024
- FDAVenlafaxine Hydrochloride extended release capsules, 37.5 mg, 30-count bottles, Rx Only, Manufactured for:February 22, 2017
- FDAVenlafaxine HCL ER Capsule USP, 150mg, packaged in a) 30-count bottles (NDC 68382-036-06), b) 90-count bottlesAugust 24, 2016
- FDAVenlafaxine HCL ER Capsule USP, 75mg, packaged in a) 30-count bottles (NDC 68382-035-06), b) 90-count bottlesAugust 24, 2016
Questions about this recall
Was Venlafaxine Hydrochloride Extended-Release Capsules, USP 37.5mg, packaged in a) 90-count bottles (NDC 68382-034-16) and b)1000-count bottles (NDC 68382-034-10), Rx only, Mfg. by: Zydus Lifesciences Ltd. Ahmedabad, India; Dist. by: Zydus Pharmaceuticals (USA) Inc. Pennington, NJ 08534 recalled?
Yes. FDA published recall D-0617-2024 on July 31, 2024. Reported hazard: Failed Dissolution Specifications: Out-of-specification results observed for dissolution testing at the 8-hour and 12-hour pull intervals.
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: VENLAFAXINE HYDROCHLORIDE. UPC: 0368382034106.